Jason Thomas GASPAR,Jacques MATHIEU,Pedro J.J. ALVAREZ,Aubrey DE GREY
申请号：
US15567121
公开号：
US20180085392A1
申请日:
2016.04.15
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Cyclodextrin compound therapeutics to reduce age-related non-bisretinoid lipofuscin in a patient having a buildup of same, said method comprising administering 2-hydroxypropyl-β-cyclodextrin, or its derivatives, or β-cyclodextrin or its derivatives, or α-cyclodextrin or its derivatives, or γ-cyclodextrin or its derivatives in an amount effective to reduce non-bisretinoid lipofuscin levels. The methods include treating and/or preventing aging of the skin, muscle and other tissues and organs, which may result in increased life-span or health-span.
